MEDIFLO: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIFLO
Largest movements
- Cash -€66,406
down €66,406 (-46.9%), from €141,502 to €75,096
mainly Contributions, distributions and other (-€193,720) and Tax, wage and social debts (-€8,975)
- Receivables within one year -€40,898
down €40,898 (-53.2%), from €76,923 to €36,025
- Reserves -€98,720
down €98,720 (-51.0%), from €193,720 to €95,000
of which Distributable reserves: -€98,720
- Tax, wage and social debts -€8,975
down €8,975 (-60.2%), from €14,907 to €5,932
- Depreciation -€11,352
down €11,352 (-67.8%), from €16,736 to €5,384
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €241,000 | €133,814 | -€107,186 | -44.5% |
| Fixed assets | 21/28 | €22,245 | €22,354 | +€109 | +0.5% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €22,245 | €22,354 | +€109 | +0.5% |
| Furniture and vehicles | 24 | €21,949 | €22,099 | +€150 | +0.7% |
| Other tangible fixed assets | 26 | €296 | €255 | -€41 | -13.9% |
| Current assets | 29/58 | €218,755 | €111,460 | -€107,295 | -49.0% |
| Amounts receivable within one year | 40/41 | €76,923 | €36,025 | -€40,898 | -53.2% |
| Other amounts receivable | 41 | €76,923 | €36,025 | -€40,898 | -53.2% |
| Cash at bank and in hand | 54/58 | €141,502 | €75,096 | -€66,406 | -46.9% |
| Deferred charges and accrued income | 490/1 | €330 | €339 | +€9 | +2.7% |
| Total equity and liabilities | 10/49 | €241,000 | €133,814 | -€107,186 | -44.5% |
| Equity | 10/15 | €225,083 | €126,110 | -€98,973 | -44.0% |
| Contributions | 10/11 | €31,000 | €31,000 | = | 0.0% |
| Reserves | 13 | €193,720 | €95,000 | -€98,720 | -51.0% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Distributable reserves | 133 | €193,720 | €95,000 | -€98,720 | -51.0% |
| Profit (loss) carried forward | 14 | €363 | €110 | -€253 | -69.7% |
| Amounts payable | 17/49 | €15,917 | €7,704 | -€8,213 | -51.6% |
| Amounts payable within one year | 42/48 | €15,917 | €7,704 | -€8,213 | -51.6% |
| Trade debts | 44 | €1,010 | €1,772 | +€762 | +75.4% |
| Suppliers | 440/4 | €1,010 | €1,772 | +€762 | +75.4% |
| Taxes, remuneration and social security | 45 | €14,907 | €5,932 | -€8,975 | -60.2% |
| Taxes | 450/3 | €14,907 | €5,932 | -€8,975 | -60.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €16,736 | €5,384 | -€11,352 | -67.8% |
| Other operating charges | 640/8 | €507 | €526 | +€19 | +3.7% |
| Gross operating margin | 9900 | €127,641 | €126,909 | -€732 | -0.6% |
| Operating profit (loss) | 9901 | €110,398 | €120,999 | +€10,601 | +9.6% |
| Financial income | 75/76B | €2,916 | €3,423 | +€507 | +17.4% |
| Recurring financial income | 75 | €2,916 | €3,423 | +€507 | +17.4% |
| Financial charges | 65/66B | €218 | €293 | +€75 | +34.4% |
| Recurring financial charges | 65 | €218 | €293 | +€75 | +34.4% |
| Profit (loss) for the period before taxes | 9903 | €113,096 | €124,129 | +€11,033 | +9.8% |
| Income taxes | 67/77 | €28,407 | €29,382 | +€975 | +3.4% |
| Profit (loss) for the period | 9904 | €84,689 | €94,747 | +€10,058 | +11.9% |
| Profit (loss) for the period to be appropriated | 9905 | €84,689 | €94,747 | +€10,058 | +11.9% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.